Sign In
Buy KROS
$11.15
+0.500 (+4.69%)
At Close: Aug 07, 2026
Keros Therapeutics Announces Pricing of Initial Public Offering of Common Stock
12:45am, Wednesday, 08'th Apr 2020
LEXINGTON, MA / ACCESSWIRE / April 7, 2020 / Keros Therapeutics, Inc. ("Keros") (KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel
